300869 康泰医学
已收盘 11-19 15:00:00
资讯
新帖
简况
康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股
证券之星 · 11-18 21:14
康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股
康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
证券之星 · 11-15
康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
证券之星 · 11-14
康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
11月14日康泰医学发布公告,其股东减持22.24万股
证券之星 · 11-14
11月14日康泰医学发布公告,其股东减持22.24万股
康泰医学(300869.SZ)股东王桂丽累计减持415.55万股
智通财经 · 11-14
康泰医学(300869.SZ)股东王桂丽累计减持415.55万股
康泰医学(300869.SZ)获得两项医疗器械注册证
智通财经 · 11-05
康泰医学(300869.SZ)获得两项医疗器械注册证
康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升
证券之星 · 10-29
康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升
康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%
证券之星 · 10-27
康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%
康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%
智通财经 · 10-27
康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%
图解康泰医学三季报:第三季度单季净利润同比减85.81%
证券之星 · 10-27
图解康泰医学三季报:第三季度单季净利润同比减85.81%
康泰医学最新公告:股东拟减持不超过1.7145%
证券之星 · 10-22
康泰医学最新公告:股东拟减持不超过1.7145%
康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股
智通财经 · 10-22
康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股
康泰医学最新公告:耳背式助听器取得医疗器械注册证
证券之星 · 09-10
康泰医学最新公告:耳背式助听器取得医疗器械注册证
康泰医学(300869.SZ)获“耳背式助听器”医疗器械注册证
智通财经 · 09-10
康泰医学(300869.SZ)获“耳背式助听器”医疗器械注册证
康泰医学最新公告:取得气囊式体外反搏装置医疗器械注册证
证券之星 · 09-04
康泰医学最新公告:取得气囊式体外反搏装置医疗器械注册证
康泰医学(300869.SZ):气囊式体外反搏装置获医疗器械注册证
智通财经 · 09-04
康泰医学(300869.SZ):气囊式体外反搏装置获医疗器械注册证
康泰医学(300869)2024年中报简析:净利润减95.53%,三费占比上升明显
证券之星 · 08-31
康泰医学(300869)2024年中报简析:净利润减95.53%,三费占比上升明显
康泰医学(300869.SZ)发布上半年业绩,净利润816.71万元,下降95.53%
智通财经 · 08-29
康泰医学(300869.SZ)发布上半年业绩,净利润816.71万元,下降95.53%
康泰医学新注册《康泰CMS1000病人监护仪嵌入式软件V1.0》项目的软件著作权
证券之星 · 08-02
康泰医学新注册《康泰CMS1000病人监护仪嵌入式软件V1.0》项目的软件著作权
康泰医学最新公告:全资子公司获得医疗器械注册证
证券之星 · 07-29
康泰医学最新公告:全资子公司获得医疗器械注册证
暂无数据
公司概况
公司名称:
康泰医学系统(秦皇岛)股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-08-24
主营业务:
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。
发行价格:
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":15.59,"timestamp":1731999831000,"preClose":15.27,"halted":0,"volume":5561349,"delay":0,"floatShares":252000000,"shares":401999999,"eps":-0.0485,"marketStatus":"已收盘","marketStatusCode":5,"change":0.32,"latestTime":"11-19 15:00:00","open":15.35,"high":15.6,"low":15.21,"amount":85897600,"amplitude":0.0255,"askPrice":15.6,"askSize":392,"bidPrice":15.59,"bidSize":226,"shortable":0,"etf":0,"ttmEps":-0.0485,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":15.27,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":16.8,"lowLimit":13.74,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401802977,"pbRate":3.22,"roa":"--","roe":"0.5%","epsLYR":0.41,"committee":0.314815,"marketValue":6264000000,"floatMarketCap":3922000000,"peRate":-321.443289,"changeRate":0.021,"turnoverRate":0.0221,"status":0},"requestUrl":"/m/hq/s/300869/tweets","defaultTab":"tweets","newsList":[{"id":"2484627340","title":"康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627340","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484627340?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:14","pubTimestamp":1731935674,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月18日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月15日公司董事,高管杨志山、高管寇国治、监事高瑞斌共减持公司股份34.58万股,占公司总股本为0.0861%。变动期间公司股价下跌3.03%,11月15日当日收盘报15.7元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800031216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2483983371","title":"康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983371?lang=zh_cn&edition=full","pubTime":"2024-11-15 21:55","pubTimestamp":1731678956,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月15日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月14日公司董事,高管杨志山、董秘,董事,高管郑敏、高管寇国治、高管刘振红、高管许云龙、监事高瑞斌共减持公司股份67.58万股,占公司总股本为0.1682%。变动期间公司股价下跌4.14%,11月14日当日收盘报16.19元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500045093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2483877106","title":"康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483877106?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:01","pubTimestamp":1731589291,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月14日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月13日公司董事,高管杨志山、董秘,董事,高管郑敏、高管寇国治、高管刘振红、高管许云龙、监事高瑞斌共减持公司股份67.58万股,占公司总股本为0.1682%。变动期间公司股价下跌2.09%,11月13日当日收盘报16.89元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400035653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2483876260","title":"11月14日康泰医学发布公告,其股东减持22.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876260","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483876260?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:01","pubTimestamp":1731585665,"startTime":"0","endTime":"0","summary":"证券之星消息,11月14日康泰医学发布公告《康泰医学:关于持股5%以上股东减持公司股份超过1%的公告》,其股东王桂丽于2024年11月13日合计减持22.24万股,占公司目前总股本的0.0554%,变动期间该股股价下跌2.09%,截止11月13日收盘报16.89元。股东增减持详情见下表:根据康泰医学2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400033593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2483820895","title":"康泰医学(300869.SZ)股东王桂丽累计减持415.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483820895","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483820895?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:59","pubTimestamp":1731581957,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司股东王桂丽累计减持公司股份415.5456万股,减持股份比例已达到公司目前总股本的1.0342%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2481152625","title":"康泰医学(300869.SZ)获得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2481152625","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481152625?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:48","pubTimestamp":1730796521,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布公告,公司于近日取得了由河北省药品监督管理局颁发的两项《中华人民共和国医疗器械注册证》,分别为:心电图机、臂式电子血压计。以上产品医疗器械注册证的取得,有利于丰富公司产品线,进一步提高公司的核心竞争力,对公司发展具有正面影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1583","159883","BK0251","BK1222","09996","300869","BK1574","09997"],"gpt_icon":0},{"id":"2479546992","title":"康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479546992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479546992?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:10","pubTimestamp":1730153418,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期康泰医学发布2024年三季报。截至本报告期末,公司营业总收入3.34亿元,同比下降45.91%,归母净利润990.29万元,同比下降94.92%。本报告期康泰医学盈利能力上升,毛利率同比增幅41.18%,净利率同比增幅15.29%。然而去年的净利率为22.19%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900005699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2478158795","title":"康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478158795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478158795?lang=zh_cn&edition=full","pubTime":"2024-10-27 17:02","pubTimestamp":1730019750,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学披露,截至2024年9月30日公司股东户数为3.5万户,较6月30日减少519.0户,减幅为1.46%。在医疗器械行业个股中,康泰医学股东户数高于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.02万户。从股价来看,2024年6月30日至2024年9月30日,康泰医学区间涨幅为27.01%,在此期间股东户数减少519.0户,减幅为1.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700013230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2478192130","title":"康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478192130","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478192130?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:50","pubTimestamp":1730019028,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布2024年第三季度报告,公司前三季度营业收入3.34亿元,同比下降45.91%;归属于上市公司股东的净利润990.29万元,同比下降94.92%;归属于上市公司股东的扣除非经常性损益的净亏损645.69万元;基本每股收益0.0246元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869"],"gpt_icon":0},{"id":"2478315884","title":"图解康泰医学三季报:第三季度单季净利润同比减85.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478315884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478315884?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:47","pubTimestamp":1730018844,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学2024年三季报显示,公司主营收入3.34亿元,同比下降45.91%;归母净利润990.29万元,同比下降94.92%;扣非净利润-645.69万元,同比下降103.53%;其中2024年第三季度,公司单季度主营收入1.22亿元,同比下降0.53%;单季度归母净利润173.58万元,同比下降85.81%;单季度扣非净利润-260.33万元,同比下降125.79%;负债率31.74%,投资收益1536.07万元,财务费用-368.11万元,毛利率49.9%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700012730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2477382342","title":"康泰医学最新公告:股东拟减持不超过1.7145%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477382342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477382342?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:00","pubTimestamp":1729594843,"startTime":"0","endTime":"0","summary":"康泰医学公告,持股5%以上股东王桂丽、董事兼高级管理人员杨志山、郑敏,监事高瑞斌,高级管理人员付春元、寇国治、许云龙、刘振红计划减持公司股份,减持比例合计不超过1.7145%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200030364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2477538450","title":"康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538450?lang=zh_cn&edition=full","pubTime":"2024-10-22 18:53","pubTimestamp":1729594431,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司股东王桂丽,董事兼高级管理人员杨志山、郑敏,监事高瑞斌,高级管理人员付春元、寇国治、许云龙、刘振红拟减持公司股份,合计拟减持不超688.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2466146481","title":"康泰医学最新公告:耳背式助听器取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2466146481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466146481?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:21","pubTimestamp":1725960085,"startTime":"0","endTime":"0","summary":"康泰医学公告,公司耳背式助听器于近日取得了由河北省药品监督管理局颁发的《中华人民共和国医疗器械注册证》,该产品适用范围为经验配,供气导性听力损失患者补偿听力用。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000028965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0251","09996","BK1222","300869","09997","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2466892664","title":"康泰医学(300869.SZ)获“耳背式助听器”医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2466892664","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466892664?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:11","pubTimestamp":1725959500,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司于近日取得了由河北省药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称:耳背式助听器,适用范围:经验配,供气导性听力损失患者补偿听力用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0251","300869","BK1574","BK1222","09997","BK1100","BK1583","09996"],"gpt_icon":0},{"id":"2464323393","title":"康泰医学最新公告:取得气囊式体外反搏装置医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2464323393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464323393?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:54","pubTimestamp":1725440070,"startTime":"0","endTime":"0","summary":"康泰医学公告,公司近日取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称为气囊式体外反搏装置,型号规格为ECP1000,用于改善成人冠状动脉供血不足的症状。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400027755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09996","300869","BK1222","09997","BK1574","BK1100","BK0251","BK1583"],"gpt_icon":0},{"id":"2464583340","title":"康泰医学(300869.SZ):气囊式体外反搏装置获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2464583340","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464583340?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:25","pubTimestamp":1725438342,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司于近日取得了由国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称气囊式体外反搏装置,该产品在医疗机构中用于改善成人冠状动脉供血不足的症状。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1179178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","09996","BK1574","BK1583","09997","BK0251","300869","BK1222"],"gpt_icon":0},{"id":"2463716500","title":"康泰医学(300869)2024年中报简析:净利润减95.53%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2463716500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463716500?lang=zh_cn&edition=full","pubTime":"2024-08-31 06:37","pubTimestamp":1725057455,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期康泰医学发布2024年中报。截至本报告期末,公司营业总收入2.12亿元,同比下降57.17%,归母净利润816.71万元,同比下降95.53%。本报告期康泰医学三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达78.6%。然而去年的净利率为22.19%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100009865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2463006584","title":"康泰医学(300869.SZ)发布上半年业绩,净利润816.71万元,下降95.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463006584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463006584?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:22","pubTimestamp":1724919721,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布2024年半年度报告,该公司营业收入为2.12亿元,同比减少57.17%。归属于上市公司股东的净利润为816.71万元,同比减少95.53%。归属于上市公司股东的扣除非经常性损益的净亏损为385.35万元。基本每股收益为0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869"],"gpt_icon":0},{"id":"2456548644","title":"康泰医学新注册《康泰CMS1000病人监护仪嵌入式软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2456548644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456548644?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:23","pubTimestamp":1722532986,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰CMS1000病人监护仪嵌入式软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权11个,较去年同期增加了1000%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200001705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2455668583","title":"康泰医学最新公告:全资子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2455668583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455668583?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:10","pubTimestamp":1722258601,"startTime":"0","endTime":"0","summary":"康泰医学公告,公司全资子公司长沙康泰医芯生物科技有限责任公司于近日收到由湖南省药品监督管理局颁发的三项《中华人民共和国医疗器械注册证》,其中血糖仪两项,血脂仪一项。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900034294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","BK1583","09997","BK1574","159883","09996","BK1222","300869"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","stockEarnings":[{"period":"1week","weight":-0.0962},{"period":"1month","weight":-0.0281},{"period":"3month","weight":0.218},{"period":"6month","weight":0.0266},{"period":"1year","weight":-0.2818},{"period":"ytd","weight":-0.2292}],"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","perCapita":"7184股","boardName":"专用设备制造业","registeredCapital":"40180万元","compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1713},{"period":"6month","weight":0.0737},{"period":"1year","weight":0.0905},{"period":"ytd","weight":0.1247}],"survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。","serverTime":1732041684758,"listedPrice":10.16,"stockholders":"35014人(较上一季度减少1.46%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}